Treatment options for anti‐HCV treatment‐experienced patients
Peter Ferenci – 26 April 2012 – Watch the interview with the authors
Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing
Diana Vetter, Michal Cohen‐Naftaly, Augusto Villanueva, Youngmin A. Lee, Peri Kocabayoglu, Rebekka Hannivoort, Goutham Narla, Josep M. Llovet, Swan N. Thung, Scott L. Friedman – 26 April 2012 – KLF6‐SV1 (SV1), the major splice variant of KLF6, antagonizes the KLF6 tumor suppressor by an unknown mechanism. Decreased KLF6 expression in human hepatocellular carcinoma (HCC) correlates with increased mortality, but the contribution of increased SV1 is unknown.
HCV infection on‐treatment viral kinetics: Do they still have a role?
Jordan J. Feld – 26 April 2012 – Watch the interview with the authors
Management of adverse events during the treatment of chronic hepatitis C infection
Douglas L. Nguyen, Timothy R. Morgan – 26 April 2012 – Watch the interview with the authors
Is there still a role for liver biopsy in managing hepatitis C virus infections?
Syed‐Mohammed R. Jafri, Stuart C. Gordon – 26 April 2012 – Watch the interview with the authors
Drug resistance: Prevalence and clinical implications during the treatment of chronic hepatitis C infection
Jean‐Michel Pawlotsky – 26 April 2012 – Watch the interview with the authors
Drug resistance: Prevalence and clinical implications during the treatment of chronic hepatitis C infection
Jean‐Michel Pawlotsky – 26 April 2012 – Watch the interview with the authors
Elevated coffee consumption and reduced risk of insulin resistance in HIV‐HCV coinfected patients (HEPAVIH ANRS CO‐13)
M. Patrizia Carrieri, Philippe Sogni, Julien Cohen, Marc‐Arthur Loko, Maria Winnock, Bruno Spire, and the HEPAVIH Study Group – 26 April 2012
Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice
Johan M. Waern, Qinggong Yuan, Urda Rüdrich, Pablo D. Becker, Kai Schulze, Helene Strick‐Marchand, Nicholas D. Huntington, Behrend J. Zacher, Karsten Wursthorn, James P. DiSanto, Carlos A. Guzman, Michael P. Manns, Michael Ott, Michael Bock – 26 April 2012 – Macrophages play an important role in the rejection of xenogeneic cells and therefore represent a major obstacle to generating chimeric mice with human xenografts that are useful tools for basic and preclinical medical research.
LecT‐hepa, a glyco‐marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients
Kiyoaki Ito, Atsushi Kuno, Yuzuru Ikehara, Masaya Sugiyama, Hiroaki Saito, Yoshihiko Aoki, Teppei Matsui, Masatoshi Imamura, Masaaki Korenaga, Kazumoto Murata, Naohiko Masaki, Yasuhito Tanaka, Shuhei Hige, Namiki Izumi, Masayuki Kurosaki, Shuhei Nishiguchi, Michiie Sakamoto, Masayoshi Kage, Hisashi Narimatsu, Masashi Mizokami – 26 April 2012 – Assessment of liver fibrosis in patients with chronic hepatitis C (CHC) is critical for predicting disease progression and determining future antiviral therapy.